Is pregnancy with polycystic ovaries prone to miscarriage?

The probability of miscarriage after pregnancy in patients with polycystic ovary syndrome is slightly higher than that in the general population, but the risk can be significantly reduced through standardized management. Polycystic ovary syndrome may affect embryo implantation and development due to endocrine disorders, insulin resistance and other factors, and requires comprehensive prevention and control through pre-pregnancy conditioning, pregnancy monitoring and drug intervention.

Patients with polycystic ovary syndrome have hyperandrogenism and insulin resistance. These two pathological conditions may interfere with endometrial receptivity and lead to difficulty in embryo implantation. Luteal corpus insufficiency is common in polycystic patients, and insufficient progesterone secretion makes it difficult to maintain early pregnancy. Some patients are accompanied by obesity, and inflammatory factors secreted by adipose tissue may damage egg quality. Clinical data shows that the spontaneous abortion rate of untreated polycystic patients can reach 30-50%, but after treatment with insulin sensitizers such as metformin, the abortion rate can be reduced to close to normal levels. Starting to take folic acid, inositol and other nutrients 3-6 months before pregnancy can help improve the quality of follicle development.

A small number of polycystic patients may be complicated by autoimmune abnormalities such as antiphospholipid antibody syndrome, which can trigger hypercoagulation in the mother and lead to placental microthrombosis. Thyroid dysfunction has a higher incidence in polycystic people, and uncontrolled hypothyroidism may directly affect fetal nervous system development. For patients with recurrent miscarriage, comorbid factors such as chromosomal abnormalities and uterine malformations need to be investigated. Monitoring of chorionic gonadotropin levels shows that the early growth rate of embryos in polycystic patients may be slower than that of ordinary pregnant women, which requires more intensive ultrasound examinations. Progesterone sustained-release vaginal gel combined with low molecular weight heparin injection can effectively improve the pregnancy outcomes of some patients.

It is recommended that patients with polycystic ovary syndrome complete comprehensive examinations such as glucose tolerance, thyroid function, and antiphospholipid antibodies before pregnancy, maintain weight gain within a reasonable range during pregnancy, and engage in 150 minutes of moderate-intensity exercise every week. Choose foods with a low glycemic index in your diet, supplement with 400 micrograms of folic acid every day until 12 weeks of pregnancy, and monitor blood pressure and urine protein regularly. If symptoms such as vaginal bleeding or abdominal pain occur, seek medical attention immediately and avoid taking miscarriage medications on your own. Through joint management of reproductive endocrinology and obstetrics, most polycystic patients can successfully achieve a healthy pregnancy.